Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the ...

Germany’s Merck KGaA has signed a collaboration with Tencent to develop digital healthcare services in China. Darmstadt-based Merck’s strategic tie-up with the China-based multinational tech ...

Merck KGaA is doubling down on AI through a new collaboration agreement with tech firm Iktos, using its generative modelling technology to speed up the discovery and design of promising new compounds.

thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) defied analyst predictions to release its first-quarter results, which were ahead of market expectations. thyssenkrupp nucera KGaA delivered a ...

J.P. Morgan analyst David Adlington maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) today and set a price target of €37.30. The company’s shares ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Revenue: €229.8m (down 1.0% from 1Q 2024). Net income: €28.9m (down 35% from 1Q 2024). Profit margin: 13% (down from 19% in 1Q 2024). The decrease in margin was primarily driven by higher ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) defied analyst predictions to release its first-quarter results, which were ahead of market expectations. thyssenkrupp nucera KGaA delivered a significant ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...